(Source: Business Wire)

TRANSCEND SERVICES, INC. (NASDAQ: TRCR), the third largest provider of
medical transcription services to the U.S. healthcare market, today
announced its unaudited results for the third quarter and nine months
ended September 30, 2009.
Third Quarter Results
Revenue for the third quarter of 2009 increased 52% to $18,491,000
compared to $12,161,000 for the third quarter of 2008. Medical Dictation
Services, Inc. ("MDSI"), which was acquired by Transcend on August 31,
2009, contributed revenue of $1,240,000 for the quarter. Excluding
revenue from the Company's three 2009 acquisitions, revenue increased
17% in the third quarter compared to the same period last year. Net
income for the third quarter of 2009 increased 24% to $1,835,000, or
$0.20 per diluted share, which included costs of $144,000, or $0.01 per
share, related to the MDSI acquisition and the termination of the
Company's previous financing arrangements. This compares to net income
for the third quarter of 2008 of $1,484,000, or $0.17 per diluted share.
"MDSI had a negligible impact on earnings per share in the third quarter
due to acquisition transaction costs and the fact that we only recorded
one month of results, but we fully expect it to be accretive to earnings
beginning in the fourth quarter. We estimate that our three 2009
acquisitions together contributed approximately $.04 to third quarter
2009 diluted earnings per share," said Chief Executive Officer Larry
Gerdes.
Gross profit for the third quarter of 2009 increased 46% to $6,574,000,
or 36% of revenue, compared to $4,518,000, or 37% of revenue, for the
third quarter of 2008. Operating expenses increased 62% to $3,595,000,
or 19% of revenue, compared to $2,221,000, or 18% of revenue, for the
third quarter of 2008.
Operating income for the third quarter of 2009 increased 30% to
$2,979,000, or 16% of revenue, compared to $2,297,000, or 19% of
revenue, for the third quarter of 2008. Operating income as a percentage
of revenue was affected by the $144,000 of costs mentioned above,
increased implementation and support costs related to acquisition
integration, and a decrease in the percentage of total revenue that was
processed on Transcend's speech recognition-enabled BeyondTXT
transcription platform in the third quarter of 2009 versus the same
period in 2008 due to the addition of non-BeyondTXT revenue from the
three acquisitions completed in 2009.
"As per our integration plan, we expect operating income margins from
our acquired businesses to be lower than our overall operating income
margins until we gradually migrate a portion of the acquired business to
our BeyondTXT platform, continue to expand our use of speech recognition
technology, and increase offshore processing," Gerdes said.
Transcend ended the third quarter of 2009 with $7,216,000 of cash and
cash equivalents on hand. During the third quarter, the Company borrowed
$7,000,000 on a new credit facility and used $9,310,000 of cash to
acquire MDSI. Adjusted to include MDSI on a pro forma basis, the Company
had 39 days of sales outstanding in accounts receivable as of September
30, 2009 (or 40 days excluding MDSI).
Nine Month Results
Results for the first nine months of 2009 include the post-acquisition
operations of MDSI, TRS and DeVenture, which were acquired by Transcend
on August 31, April 1 and January 1, 2009, respectively.
For the nine months ended September 30, 2009, revenue increased 40% to
$50,387,000 compared to $35,863,000 for the first nine months of 2008.
Excluding revenue from the Company's three 2009 acquisitions, revenue
increased 16% for the first nine months of 2009 compared to the same
period last year. The gross profit margin was 36% for both periods.
Operating income for this year's first nine months increased 25% to
$8,347,000 compared to $6,664,000 for the same period last year. Net
income for the first nine months of 2009 increased 21% to $5,169,000, or
$0.58 per diluted share, compared to $4,279,000, or $0.49 per diluted
share, for the first nine months of 2008. The Company's three 2009
acquisitions together contributed approximately $.07 to earnings per
share for the nine months ended September 30, 2009.
Operations Review and Outlook
Mr. Gerdes continued, "Three milestone events occurred during the third
quarter. First, the acquisition of MDSI added a business generating over
$14 million of revenue per year as of the acquisition date and brought a
wonderful group of customers and employees to Transcend. Second, we
signed a five-year single-source agreement with Health Management
Associates ("HMA") to expand our services from the 45 hospitals we
already serve to all 56 HMA hospitals. Finally, we promoted Sue McGrogan
to President of Transcend in addition to her previous role as Chief
Operating Officer. Sue deserves much of the credit for the
customer-centric culture that has been fundamental to Transcend's
success over the last several years."
Leo Cooper, Executive Vice President of Sales and Marketing, added,
"During the third quarter we closed sales that we estimate will generate
between $3.5 million and $4.4 million of annual revenue once fully
implemented. This includes between $1.6 million and $2.0 million of
incremental revenue related to the HMA agreement. While our sales in the
past have predominantly been to individual hospitals, in the future we
believe that more purchasing decisions will be made at the group level.
Because of our reputation for service excellence, we believe we are
well-positioned to compete successfully for this hospital system
business."
Sue McGrogan, President and Chief Operating Officer said, "We now expect
a 95% retention rate for 2009, versus the 92% rate we estimated last
quarter. The reason is that in September we lost a large customer to a
small competitor based on price. The customer had such severe problems
with the new transcription firm that they quickly decided to terminate
their agreement and return to Transcend. Our relationship with this
customer is now stronger than ever. Experiences like this are why we are
committed first and foremost to providing the best service in the
industry."
Lance Cornell, Chief Financial Officer, stated, "For each of our
acquisitions, we first complete the organizational and back-office
integration, then work to improve margins by migrating as much of the
customer base as possible to our BeyondTXT platform. Both of these
phases of the DeVenture integration are complete. The first phase of the
TRS integration is complete, and the second phase will continue over the
next several quarters. We expect to complete the first phase of the MDSI
integration in the first quarter of 2010, with the second phase
stretching throughout 2010."
Mr. Gerdes concluded, "Based on annualized September revenue,
Transcend's annual revenue run rate reached a record $84.1 million,
which does not include the impact of recent sales. Our team has proven
that it can manage rapid growth while continuing to deliver excellent
service to our customers. Our success was recently recognized by Forbes,
which ranked Transcend the 6th best performing small public
company in the U.S. based on one and five-year sales growth, earnings
per share growth and return on equity. I want to thank our employees for
making our company so successful and our customers for placing their
trust in Transcend."
Conference Call
Transcend will host a conference call regarding this press release for
investors, analysts and other interested parties on October 28, 2009 at
11:00 a.m. ET. To participate in the conference call, please dial (800)
815-8193 (the US/Canada dial-in number) or (706) 643-2724 (the
international dial-in number), enter the conference identification
number 33661006 and, if asked, identify the conference name as Transcend
Services and the leader name as Larry Gerdes. A replay of the conference
call will be available by dialing (800) 642-1687 (US/Canada) or (706)
645-9291 (international) and entering the conference identification
number 33661006 from two hours after the completion time of the
conference call until midnight on November 4, 2009.
About Transcend Services, Inc.
Transcend believes that accurate, reliable and timely transcription
creates the foundation for the patient medical record.